Literature DB >> 6888571

Effect of calcium-antagonist and calmodulin-antagonist drugs on calmodulin-dependent contractions of chemically skinned vascular smooth muscle from rabbit renal arteries.

V A Kreye, J C Rüegg, F Hofmann.   

Abstract

1. Renal arteries from rabbits were chemically skinned by incubation with Triton X-100, and subsequently stored in buffered glycerol. 2. In the presence of Mg-ATP, of EGTA-buffered calcium, and of calmodulin, miniature strips of the skinned arteries developed tension the strength of which was approx. 15-20% of that of viable renal arteries. 3. Tension development was dependent on the concentration of both calcium and calmodulin. 4. The effect of eight vasodilator drugs, the majority of them being "calmodulin antagonists" or "calcium antagonists", on the skinned arteries was assessed. In concentrations up to 10(-3) M, verapamil, D-600, and hydralazine proved to be ineffective, and the same was found with the dihydropyridine derivatives, nifedipine and felodipine, at 0.6 X 10(-3) M and 0.8 X 10(-4) M, respectively, i.e. at saturation in a 9:1 contracting buffer/ethanol mixture (v/v). 5. In a concentration-dependent manner, trifluoperazine, W-7, and fendiline relaxed Ca-calmodulin-induced tension or prevented tension development when given prior to the activation by Ca-calmodulin. However, considerably higher concentrations of the drugs were necessary for half-maximal relaxation than the reported concentrations for half-maximal saturation of hydrophobic binding sites at the calmodulin molecule. 6. These findings suggest that at therapeutic blood levels, the vasodilator properties of calcium antagonists and other direct vasodilators cannot be explained by interference with the binding of myosin light chain kinase to calmodulin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6888571     DOI: 10.1007/bf00634253

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

1.  Ca2+ dependent phosphorylation of bovine aortic actomyosin.

Authors:  J DiSalvo; E Gruenstein; P Silver
Journal:  Proc Soc Exp Biol Med       Date:  1978-07

2.  Interaction of calmodulin with skeletal muscle myosin light chain kinase.

Authors:  T H Crouch; M J Holroyde; J H Collins; R J Solaro; J D Potter
Journal:  Biochemistry       Date:  1981-10-27       Impact factor: 3.162

3.  Calcium-sensitivity of pig-carotid-actomyosin ATPase in relation to phosphorylation of the regulatory light chain.

Authors:  U Mrwa; M Troschka; C Gross; L Katzinski
Journal:  Eur J Biochem       Date:  1980-01

Review 4.  Regulation and kinetics of the actin-myosin-ATP interaction.

Authors:  R S Adelstein; E Eisenberg
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

5.  Calmodulin is essential for smooth muscle contraction.

Authors:  M P Sparrow; U Mrwa; F Hofmann; J C Rüegg
Journal:  FEBS Lett       Date:  1981-03-23       Impact factor: 4.124

6.  Interaction of the antihypertensive drug felodipine with calmodulin.

Authors:  S L Bostróm; B Ljung; S Mårdh; S Forsen; E Thulin
Journal:  Nature       Date:  1981-08-20       Impact factor: 49.962

7.  Hydrophobic regions function in calmodulin-enzyme(s) interactions.

Authors:  T Tanaka; H Hidaka
Journal:  J Biol Chem       Date:  1980-12-10       Impact factor: 5.157

8.  Calcium-induced exposure of a hydrophobic surface on calmodulin.

Authors:  D C LaPorte; B M Wierman; D R Storm
Journal:  Biochemistry       Date:  1980-08-05       Impact factor: 3.162

9.  Studies on the direct vasodilator effect of hydralazine in the isolated rabbit renal artery.

Authors:  M Khayyal; F Gross; V A Kreye
Journal:  J Pharmacol Exp Ther       Date:  1981-02       Impact factor: 4.030

10.  Calcium antagonists affect calmodulin-dependent contractility of a skinned smooth muscle.

Authors:  H Metzger; H O Stern; G Pfitzer; J C Rüegg
Journal:  Arzneimittelforschung       Date:  1982
View more
  9 in total

1.  Calcium channel antagonists: pharmacological considerations.

Authors:  D Rampe; C M Su; F Yousif; D J Triggle
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

2.  The positive inotropic dihydropyridine Bay K 8644 does not affect calcium sensitivity or calcium release of skinned cardiac fibres.

Authors:  G Thomas; R Gross; G Pfitzer; J C Rüegg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

3.  Mechanisms of hydralazine induced vasodilation in rabbit aorta and pulmonary artery.

Authors:  D C Ellershaw; A M Gurney
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

4.  Blockade by calmodulin inhibitors of Ca2+ channels in smooth muscle from rat vas deferens.

Authors:  K Nakazawa; K Higo; K Abe; Y Tanaka; H Saito; N Matsuki
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

5.  Calcium antagonist and antiperoxidant properties of some hindered phenols.

Authors:  G P Sgaragli; M Valoti; B Gorelli; F Fusi; M Palmi; P Mantovani
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

6.  Inhibition of calcium release from the sarcoplasmic reticulum of rabbit aorta by hydralazine.

Authors:  A M Gurney; M Allam
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

7.  Haemodynamic effects of intravenous felodipine in normotensive and hypertensive subjects.

Authors:  H E Sluiter; F T Huysmans; T A Thien; R A Koene
Journal:  Drugs       Date:  1985       Impact factor: 9.546

8.  Effect of calcium and calmodulin antagonists on contractile responses of the human uterine artery.

Authors:  A Kostrzewska; T Laudanski; S Batra
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

9.  Barium can replace calcium in calmodulin-dependent contractions of skinned renal arteries of the rabbit.

Authors:  V A Kreye; F Hofmann; M Mühleisen
Journal:  Pflugers Arch       Date:  1986-03       Impact factor: 3.657

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.